All eyes on a hurdle race for a SARS-CoV-2 vaccine.

Gaebler, Christian; Nussenzweig, Michel C

Gaebler, Christian; Nussenzweig, Michel C.

Nature ; 586(7830): 501-502, 2020 10.

Article in English | MEDLINE | ID: covidwho-880678

Subject(s)

Clinical Trials as Topic; Coronavirus Infections/immunology; Pneumonia, Viral/immunology; Viral Vaccines/immunology; Adolescent; Adult; B-Lymphocytes/immunology; Betacoronavirus/immunology; COVID-19; COVID-19 Vaccines; Coronavirus Infections/epidemiology; Coronavirus Infections/prevention & control; Humans; Middle Aged; Pandemics/prevention & control; Pneumonia, Viral/epidemiology; Pneumonia, Viral/prevention & control; SARS-CoV-2; T-Lymphocytes/immunology; United States; United States Food and Drug Administration/legislation & jurisprudence; Vaccination; Viral Vaccines/administration & dosage; Viral Vaccines/adverse effects; Young Adult

Keywords

Immunology; Medical research; SARS-CoV-2; Vaccines

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Viral Vaccines / Clinical Trials as Topic / Coronavirus Infections Type of study: Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Adolescent / Adult / Humans / Middle aged / Young adult Country/Region as subject: North America Language: English Journal: Nature Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google